Camerini D, Su H P, Gamez-Torre G, Johnson M L, Zack J A, Chen I S
Department of Microbiology and Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia 22908, USA.
J Virol. 2000 Apr;74(7):3196-204. doi: 10.1128/jvi.74.7.3196-3204.2000.
Human immunodeficiency virus type 1 (HIV-1) patient isolates and molecular clones were used to analyze the determinants responsible for human CD4(+) thymocyte depletion in SCID-hu mice. Non-syncytium-inducing, R5 or R3R5 HIV-1 isolates from asymptomatic infected people showed little or no human CD4(+) thymocyte depletion in SCID-hu mice, while syncytium-inducing (SI), R5X4 or R3R5X4 HIV-1 isolates from the same individuals, isolated just prior to the onset of AIDS, rapidly and efficiently eliminated CD4-bearing human thymocytes. We have mapped the ability of one SI HIV-1 isolate to eliminate CD4(+) human cells in SCID-hu mice to a region of the env gene including the three most amino-terminal variable regions (V1 to V3). We find that for all of the HIV-1 isolates that we studied, a nonlinear relationship exists between viral replication and the depletion of CD4(+) cells. This relationship can best be described mathematically with a Hill-type plot indicating that a threshold level of viral replication, at which cytopathic effects begin to be seen, exists for HIV-1 infection of thymus/liver grafts in SCID-hu mice. This threshold level is 1 copy of viral DNA for every 11 cells (95% confidence interval = 1 copy of HIV-1 per 67 cells to 1 copy per 4 cells). Furthermore, while SI viruses more frequently achieve this level of replication, replication above this threshold level correlates best with cytopathic effects in this model system. We used GHOST cells to map the coreceptor specificity and relative entry efficiency of these early- and late-stage patient isolates of HIV-1. Our studies show that coreceptor specificity and entry efficiency are critical determinants of HIV-1 pathogenesis in vivo.
1型人类免疫缺陷病毒(HIV-1)患者分离株和分子克隆被用于分析在SCID-hu小鼠中导致人类CD4(+)胸腺细胞耗竭的决定因素。来自无症状感染者的非合胞体诱导型、R5或R3R5 HIV-1分离株在SCID-hu小鼠中几乎没有或没有导致人类CD4(+)胸腺细胞耗竭,而来自同一患者且在艾滋病发病前不久分离出的合胞体诱导型(SI)、R5X4或R3R5X4 HIV-1分离株则能快速有效地清除携带CD4的人类胸腺细胞。我们已将一种SI HIV-1分离株在SCID-hu小鼠中清除CD4(+)人类细胞的能力定位到env基因的一个区域,该区域包括最靠近氨基端的三个可变区(V1至V3)。我们发现,对于我们研究的所有HIV-1分离株,病毒复制与CD4(+)细胞耗竭之间存在非线性关系。用希尔型图能最好地从数学上描述这种关系,这表明在SCID-hu小鼠的胸腺/肝脏移植物的HIV-1感染中,存在一个病毒复制的阈值水平,在这个水平上开始出现细胞病变效应。这个阈值水平是每11个细胞中有1份病毒DNA(95%置信区间 = 每67个细胞中有1份HIV-1至每4个细胞中有1份)。此外,虽然SI病毒更频繁地达到这个复制水平,但在这个模型系统中,高于这个阈值水平的复制与细胞病变效应的相关性最好。我们使用GHOST细胞来确定这些HIV-1早期和晚期患者分离株的共受体特异性和相对进入效率。我们的研究表明,共受体特异性和进入效率是HIV-1体内发病机制的关键决定因素。